Efficacy and Safety of CD5024 1% in Acne Vulgaris

NCT03034460 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne

Interventions

DRUG: CD5024 1% cream
DRUG: CD5024 cream placebo
DRUG: CD0271/CD1579 gel
DRUG: CD0271/CD1579 gel placebo

Sponsor

Galderma R&D